In an experimental model of allergic asthma utilizing rats, the silencing of ADAM33 has been proven to decrease the proliferation of ASMCs while concurrently enhancing apoptosis (Zhou et al. 2019). This evidence concerns the gene ADAM33 and allergic asthma.